...will remain as an adviser. Kosaraju was president of medical device company Penumbra Inc. (NYSE:PEN).Ophthalmic company Oculis...

...Alzheimer’s disease, obsessive-compulsive disorder and spinocerebellar ataxia. Phase II win for Oculis in macular edema Oculis...

...participation by existing investors Brunnur Ventures and Silfurberg. Oculis also hired Riad Sherif as CEO. Oculis...
...Markabi, who was Alcon's SVP, CMO and head of R&D, will become Oculis' CSO, and Oculis...
...round led by Brunnur Ventures and Silfurberg. Oculis S.A., Lausanne, Switzerland Mary Romeo Actavis plc Alcon Inc. Allergan plc Novartis AG Oculis...

...investors Brunnur Ventures and Silfurberg also participated. The round includes an initial CHF18 million tranche. Oculis...
...therapy is a topical dexamethasone formulation developed using the company's Solubilizing Nanoparticle (SNP) technology platform. Oculis...
...Markabi, who was Alcon's SVP, CMO and head of R&D, will become Oculis' CSO, and Oculis...